Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in US hospital discharge records: A cross-sectional study

Sexually Transmitted Infections

Volumn 88, Issue 7, 2012, Pages 528-533

  Nouraie, Mehdi ^a   Nekhai, Sergei ^a   Gordeuk, Victor R ^a  

^a HOWARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANEMIA, SICKLE CELL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84871387358     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050459     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention (CDC). HIV surveillance - United States, 1981-2008. MMWR Morb Mortal Wkly Rep 2011;60:689-93.
2. Brousseau DC, Panepinto JA, Nimmer M, et al. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol 2010;85:77-8.
3. Castro O, Saxinger C, Barnes S, et al. Prevalence of antibodies to human immunodeficiency virus and to human T cell leukemia virus type I in transfused sickle cell disease patients. J Infect Dis 1990;162:743-5. (Pubitemid 20266171)
4. Bagasra O, Steiner RM, Ballas SK, et al. Viral burden and disease progression in HIV-1-infected patients with sickle cell anemia. Am J Hematol 1998; 59:199-207. (Pubitemid 28485500)
5. Kourtis AP, Bansil P, Johnson C, et al. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States. Pediatr Infect Dis J 2007;26:406-10. (Pubitemid 46789321)
6. Batina Agasa S, Dupont E, Kayembe T, et al. Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010;17:254-9.
7. Batina A, Kabemba S, Malengela R. [Infectious markers among blood donors in Democratic Republic of Congo (DRC)]. Rev Med Brux 2007;28:145-9.
8. Neto JP, Lyra IM, Reis MG, et al. The association of infection and clinical severity in sickle cell anaemia patients. Trans R Soc Trop Med Hyg 2011;105:121-6.
9. USAID. Brazil HIV/AIDS Health profile. 2010.
10. Hall MJ, DeFrances CJ, Williams SN, et al. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report 2010:1-20, 24.
11. Volberding PA, Deeks SG. Antiretroviral therapy for HIV infection: promises and problems. JAMA 1998;279:1343-4. (Pubitemid 28198794)
12. Lanzkron S, Haywood C Jr, Hassell KL, et al. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network. J Natl Med Assoc 2008;100:968-73.
13. U.S. Census Bureau. 2010 Census Data, 2011.
14. HIV Surveillance by Race/Ethnicity (through 2009). Atlanta: Centers for Disease Control and Prevention, 2011.
15. Zemel BS, Kawchak DA, Ohene-Frempong K, et al. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 2007;61:607-13. (Pubitemid 46650016)
16. Zago MA, Kerbauy J, Souza HM, et al. Growth and sexual maturation of Brazilian patients with sickle cell diseases. Trop Geogr Med 1992;44:317-21. (Pubitemid 23040640)
17. Samuels-Reid JH, Scott RB, Brown WE. Contraceptive practices and reproductive patterns in sickle cell disease. J Natl Med Assoc 1984;76:879-83. (Pubitemid 14039459)
18. Alleyne SI, Rauseo RD, Serjeant GR. Sexual development and fertility of Jamaican female patients with homozygous sickle cell disease. Arch Intern Med 1981;141:1295-7. (Pubitemid 11054288)
19. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 2005;79:17-25. (Pubitemid 40604787)
20. Steinke DT, Weston TL, Morris AD, et al. Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut 2002; 50:100-5. (Pubitemid 34028311)
21. Hsieh YH, Rothman RE, Bartlett JG, et al. HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr 2008;49:398-405.
22. Telenti A, Goldstein DB. Genomics meets HIV-1. Nat Rev Microbiol 2006;4:865-73. (Pubitemid 44593953)
23. Kaur G, Mehra N. Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens 2009;73:289-301.
24. Jison ML, Munson PJ, Barb JJ, et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 2004;104:270-80. (Pubitemid 38879868)
25. Bains SK, Foresti R, Howard J, et al. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity. Arterioscler Thromb Vasc Biol 2010;30:305-12.
26. Belcher JD, Mahaseth H, Welch TE, et al. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 2006;116:808-16. (Pubitemid 43326890)
27. Devadas K, Dhawan S. Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. J Immunol 2006;176:4252-7. (Pubitemid 44264404)
28. Devadas K, Hewlett IK, Dhawan S. Lipopolysaccharide suppresses HIV-1 replication in human monocytes by protein kinase C-dependent heme oxygenase-1 induction. J Leukoc Biol 2010;87:915-24.
29. Ammosova T, Washington K, Debebe Z, et al. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Retrovirology 2005;2:47.
30. Charles S, Ammosova T, Cardenas J, et al. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration. J Cell Physiol 2009; 221:469-79.
31. Campbell A, Minniti CP, Nouraie M, et al. Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients. Br J Haematol 2009;147:352-9.
32. Niu X, Nouraie M, Campbell A, et al. Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease. PLoS One 2009;4:e7956.
33. Naicker DD, Werner L, Kormuth E, et al. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 2009;200:448-52.
34. Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in ironover-loaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006;135:254-63. (Pubitemid 44401624)
35. Carrington M, Nelson G, O'Brien SJ. Considering genetic profiles in functional studies of immune responsiveness to HIV-1. Immunol Lett 2001;79:131-40. (Pubitemid 32938218)
36. Debebe Z, Ammosova T, Breuer D, et al. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targetseiron, cyclin-dependent kinase (CDK) 2, and CDK9. Mol Pharmacol 2011;79:185-96.
37. Debebe Z, Ammosova T, Jerebtsova M, et al. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology 2007;367:324-33. (Pubitemid 47494537)
38. Xu M, Kashanchi F, Foster A, et al. Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 2010;7:104.
39. Kroot JJ, Laarakkers CM, Kemna EH, et al. Regulation of serum hepcidin levels in sickle cell disease. Haematologica 2009;94:885-7.
40. He W, Neil S, Kulkarni H, et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008;4:52-62. (Pubitemid 351944053)
41. Nebor D, Durpes MC, Mougenel D, et al. Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Clin Immunol 2010; 136:116-22.
42. Rivera A, Jarolim P, Brugnara C. Modulation of Gardos channel activity by cytokines in sickle erythrocytes. Blood 2002;99:357-603.
43. Romanelli F, Hoven AD. Use of virostatics as a means of targeting human immunodeficiency virus infection. Curr Pharm Des 2006;12:1121-7.
44. Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009;58:1-27.
45. Hassan M, Hasan S, Giday S, et al. Hepatitis C virus in sickle cell disease. J Natl Med Assoc 2003;95:939-42. (Pubitemid 37296668)
46. Ocak S, Kaya H, Cetin M, et al. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res 2006;37:895-8. (Pubitemid 44333149)